Nadia Alatrakchi

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi Regulatory T cells and viral liver disease
    Nadia Alatrakchi
    Infectious Diseases Division, BIDMC and Harvard Medical School, Boston, MA 02115, USA
    J Viral Hepat 16:223-9. 2009
  2. ncbi CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection
    Nadia Alatrakchi
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Infect Dis 191:702-9. 2005
  3. pmc Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses
    Nadia Alatrakchi
    Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Boston, MA 02115, USA
    J Virol 81:5882-92. 2007
  4. pmc Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis
    Shaoyong Li
    Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA
    Hepatology 56:2094-105. 2012
  5. ncbi A tale of two viruses: hepatitis C in the age of HAART
    Nadia Alatrakchi
    Infectious Disease Division, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Lancet 362:1687-8. 2003
  6. pmc Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects
    Mark A Exley
    Department of Medicine, Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Clin Immunol 140:184-95. 2011
  7. ncbi Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection
    Nadia Alatrakchi
    Laboratoire d Immunologie Cellulaire, INSERM U 543, Hopital Pitie Salpetriere, Paris, France
    AIDS 20:29-34. 2006
  8. ncbi Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus
    Nadia Alatrakchi
    Laboratoire d Immunologie Cellulaire, GH Pitié Salpétrière, Paris, France
    AIDS 16:713-7. 2002
  9. ncbi Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection
    Nadia Alatrakchi
    Laboratoire d Immunologie Cellulaire et Tissulaire INSERM U543, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    AIDS 18:121-3. 2004
  10. ncbi Antiviral T-cell responses and therapy in chronic hepatitis B
    Nadia Alatrakchi
    J Hepatol 39:631-4. 2003

Detail Information

Publications10

  1. doi Regulatory T cells and viral liver disease
    Nadia Alatrakchi
    Infectious Diseases Division, BIDMC and Harvard Medical School, Boston, MA 02115, USA
    J Viral Hepat 16:223-9. 2009
    ..Here, we will review progress to date on understanding Treg populations in regard to viral hepatitis...
  2. ncbi CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection
    Nadia Alatrakchi
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Infect Dis 191:702-9. 2005
    ..We sought to determine whether T cell responses were present in the liver of patients with human immunodeficiency virus (HIV) and HCV coinfection...
  3. pmc Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses
    Nadia Alatrakchi
    Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Boston, MA 02115, USA
    J Virol 81:5882-92. 2007
    ..In conclusion, blockade of TGF-beta secretion could enhance peripheral HCV-specific T-cell responses even in the presence of HIV coinfection...
  4. pmc Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis
    Shaoyong Li
    Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA
    Hepatology 56:2094-105. 2012
    ..46, P = 0.05). In addition, supernatants from HCV-stimulated IHL of slow progressors specifically increased fibrolytic gene expression in HSC and treatment with anti-TGFβ mAb abrogated such expression...
  5. ncbi A tale of two viruses: hepatitis C in the age of HAART
    Nadia Alatrakchi
    Infectious Disease Division, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Lancet 362:1687-8. 2003
  6. pmc Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects
    Mark A Exley
    Department of Medicine, Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Clin Immunol 140:184-95. 2011
    ....
  7. ncbi Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection
    Nadia Alatrakchi
    Laboratoire d Immunologie Cellulaire, INSERM U 543, Hopital Pitie Salpetriere, Paris, France
    AIDS 20:29-34. 2006
    ..To evaluate HIV-2-specific proliferative, interferon (IFN)gamma- and interleukin (IL)-2-producing T-cell responses in HIV-2 infection and their relationship with plasma HIV-2 RNA...
  8. ncbi Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus
    Nadia Alatrakchi
    Laboratoire d Immunologie Cellulaire, GH Pitié Salpétrière, Paris, France
    AIDS 16:713-7. 2002
    ..To compare the T-cell responses to hepatitis C virus (HCV) and HIV in HIV-infected long-term non-progressors (LT-NP) and HIV-positive progressors co-infected with HCV and in HIV-negative HCV-infected patients...
  9. ncbi Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection
    Nadia Alatrakchi
    Laboratoire d Immunologie Cellulaire et Tissulaire INSERM U543, Centre Hospitalier Universitaire Pitie Salpetriere, Paris, France
    AIDS 18:121-3. 2004
    ..This suggests that IFN+R therapy might compromise virus-specific immune defenses in immunosuppressed patients...
  10. ncbi Antiviral T-cell responses and therapy in chronic hepatitis B
    Nadia Alatrakchi
    J Hepatol 39:631-4. 2003